Fertility-sparing treatment in MSI-H/MMRd endometrial carcinoma or atypical endometrial hyperplasia: A systematic review and meta-analysis.
Tianyu ZhangXinyue ZhangPeng PengJiaxin Yang
Published in: European journal of obstetrics, gynecology, and reproductive biology (2024)
EC and AEH patients with the MSI-H/MMRd subtype had a low remission rate and high recurrence rate compared to conservative treatment. Caution is recommended when evaluating fertility-sparing therapy for patients with the MSI-H/MMRd subtype.